Publications by authors named "Chingyu Su"

Claim this Profile
P
Phase 1 trial of durvalumab (anti-PD-L1) combined with lenalidomide in relapsed/refractory cutaneous T-cell lymphoma.
Christiane Querfeld, Joycelynne Palmer, Zhen Han, Xiwei Wu, Yate-Ching Yuan, Min-Hsuan Chen, Chingyu Su

Blood Adv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reprogramming of PD-1+ M2-like tumor-associated macrophages with anti-PD-L1 and lenalidomide in cutaneous T cell lymphoma.
Zhen Han, Xiwei Wu, Hanjun Qin, Yate-Ching Yuan, Daniel Schmolze, Chingyu Su

JCI Insight· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA Regulation of T-Cell Exhaustion in Cutaneous T Cell Lymphoma.
Zhen Han, Renee J Estephan, Xiwei Wu, Chingyu Su, Yate-Ching Yuan, Sung Hee Kil

J Invest Dermatol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a Distinct miRNA Regulatory Network in the Tumor Microenvironment of Transformed Mycosis Fungoides.
Cosimo Di Raimondo, Zhen Han, Chingyu Su, Xiwei Wu, Hanjun Qin

Cancers (Basel)· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis